{"gene":"PRF1","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1986,"finding":"Perforin (PFP) was purified from granules of cloned NK-like cytolytic cells and shown to form Ca2+-dependent transmembrane pores of ~160 Å diameter in target cell membranes, depolarizing cells and making lipid vesicles leaky; the protein formed large (averaging ~400 pS), voltage-insensitive, nonselective ion channels in planar bilayers, functionally and morphologically similar to lesions formed by intact NK cells.","method":"Protein purification from cytolytic granules; planar lipid bilayer electrophysiology; liposome leakage assays; electron microscopy of membrane lesions","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in vitro with purified protein, multiple orthogonal methods, foundational discovery","pmids":["2420467"],"is_preprint":false},{"year":1986,"finding":"Structural and functional homologies between perforin (PFP) and complement component C9 were demonstrated: monospecific antibodies to purified C9 and PFP showed cross-reactivity, and both proteins polymerize to form tubular membrane lesions (100 Å for C9, 160 Å for PFP) that create stable, nonselective, voltage-insensitive aqueous pores; perforin polymerization requires Ca2+.","method":"Immunological cross-reactivity assays; electron microscopy; planar lipid bilayer electrophysiology; Zn2+-induced polymerization of C9","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — biochemical reconstitution and structural comparison, replicated across labs","pmids":["2425429"],"is_preprint":false},{"year":1988,"finding":"Human perforin cDNA was isolated; the deduced amino acid sequence showed 68.4% similarity to mouse perforin and confirmed structural homology to complement component C9 at functionally conserved regions; perforin expression was restricted to killer-type cells (NK cells and cytotoxic T lymphocytes) among cell lines tested.","method":"cDNA cloning and sequencing; RNA blot analysis; sequence comparison","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — primary structure determination confirming C9 homology, replicated with mouse perforin","pmids":["3419519","3261391","2592021"],"is_preprint":false},{"year":1988,"finding":"Mouse perforin cDNA was cloned and sequenced; the deduced primary structure has homology with C9 at their respective functionally conserved regions, providing direct molecular evidence that a killer-cell-specific protein evolutionarily linked to C9 is involved in cell-mediated cytolysis.","method":"cDNA library screening with oligonucleotide probes derived from N-terminal amino acid sequencing; sequence analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — primary structure determination; replicated contemporaneously","pmids":["3261391"],"is_preprint":false},{"year":1989,"finding":"Human perforin (PFP) gene was mapped to chromosome 17q11-21 by in situ hybridization, and perforin mRNA was found to be expressed preferentially in killer-type cells and large granular lymphocytes.","method":"cDNA isolation; RNA blot analysis; in situ hybridization for chromosomal mapping","journal":"Immunogenetics","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal localization by in situ hybridization","pmids":["2592021"],"is_preprint":false},{"year":1998,"finding":"Granulysin in combination with perforin decreased the viability of intracellular Mycobacterium tuberculosis; the ability of CTLs to kill intracellular M. tuberculosis was dependent on the presence of granulysin in cytotoxic granules, defining a mechanism by which T cells directly contribute to immunity against intracellular pathogens requiring perforin to deliver granulysin.","method":"CTL killing assays; granulysin-deficient cell functional studies; intracellular killing assays with M. tuberculosis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — functional reconstitution showing perforin cooperates with granulysin for intracellular pathogen killing","pmids":["9756476"],"is_preprint":false},{"year":1999,"finding":"Loss-of-function mutations in the perforin gene (PRF1) were identified as the cause of 10q21-22-linked familial hemophagocytic lymphohistiocytosis (FHL); homozygous nonsense and missense mutations in PRF1 were found in FHL patients, cultured lymphocytes had defective cytotoxic activity, and immunostaining revealed little or no perforin in granules, demonstrating that perforin-based effector systems are required for down-regulation of cellular immune activation.","method":"Gene sequencing; NK/CTL cytotoxicity assays; immunostaining of granules","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — genetic and functional demonstration replicated across multiple patients","pmids":["10583959"],"is_preprint":false},{"year":2000,"finding":"Perforin-deficient mice exhibited increased expansion and decreased death of antigen-specific CD8+ T cells after Listeria monocytogenes infection, demonstrating that perforin controls CD8+ T cell expansion (homeostasis) independently of its antimicrobial effector role; IFN-γ controlled immunodominance and the death phase by a separate mechanism.","method":"Perforin-deficient and IFN-γ-deficient mouse infection model; flow cytometry of antigen-specific CD8+ T cells","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, epistasis between perforin and IFN-γ","pmids":["11082062"],"is_preprint":false},{"year":2002,"finding":"Granzyme B (GrB) and perforin coexist as multimolecular complexes with the proteoglycan serglycin in cytotoxic granules; cytotoxic cells secrete macromolecular GrB-serglycin complexes; monomeric perforin and perforin-serglycin complexes mediate cytosolic delivery of macromolecular GrB-serglycin without producing detectable plasma membrane pores, indicating a multimeric modular delivery system (serglycin=scaffold, perforin=translocator, granzyme=effector).","method":"Co-immunoprecipitation; gel filtration; cytotoxicity assays; membrane permeabilization assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical reconstitution of complexes plus functional delivery assay","pmids":["11911826"],"is_preprint":false},{"year":2010,"finding":"The X-ray crystal structure of monomeric murine perforin was determined and a cryo-electron microscopy reconstruction of the entire perforin pore was obtained. Perforin is a thin 'key-shaped' molecule comprising: an N-terminal MACPF/CDC domain, an EGF domain forming a central shelf with the C-terminal sequence, and a C-terminal C2 domain that mediates initial Ca2+-dependent membrane binding. The MACPF domain orientation in the perforin pore is inside-out relative to CDC subunit arrangement, revealing remarkable mechanistic flexibility in the MACPF/CDC fold. More than 50 FHL-linked perforin mutations mapped onto this structure.","method":"X-ray crystallography; cryo-electron microscopy reconstruction; structure-function mapping of disease mutations","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure plus cryo-EM pore reconstruction, structural basis for mechanism and disease mutations","pmids":["21037563"],"is_preprint":false},{"year":2010,"finding":"Acid sphingomyelinase (ASM) is released extracellularly when cells are wounded by perforin in the presence of Ca2+; ASM-deficient cells undergo lysosomal exocytosis after wounding but are defective in injury-dependent endocytosis and plasma membrane repair; exogenous recombinant ASM restores endocytosis and resealing, demonstrating that conversion of plasma membrane sphingomyelin to ceramide by ASM promotes internalization of perforin lesions.","method":"Cell wounding assays; ASM-deficient cells; rescue with recombinant ASM; endocytosis and membrane resealing assays","journal":"Journal of Cell Biology","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function and biochemical rescue demonstrating mechanism of perforin pore removal","pmids":["20530211"],"is_preprint":false},{"year":2011,"finding":"Perforin induces a transient Ca2+ flux in the target cell triggering endocytosis of both perforin and granzymes into enlarged endosomes ('gigantosomes'); perforin then forms pores in the gigantosome membrane, allowing endosomal cargo including granzymes to be gradually released into the cytosol; after ~15 min gigantosomes rupture releasing remaining contents. This two-step mechanism (plasma membrane pore → endocytosis → endosomal pore → cytosolic release) delivers granzymes to the target cell cytosol.","method":"Live-cell time-lapse microscopy; Ca2+ flux measurements; endosomal fractionation; fluorescent granzyme tracking","journal":"Nature Immunology","confidence":"High","confidence_rationale":"Tier 1–2 — direct visualization with multiple orthogonal approaches defining mechanistic pathway","pmids":["21685908"],"is_preprint":false},{"year":2013,"finding":"Using biochemical approaches combined with time-lapse microscopy of human primary cytotoxic lymphocytes, perforin pores were shown to assemble on the target cell plasma membrane within 30 seconds of recognition, enabling rapid diffusion of extracellular granzymes into the target cell through transient plasma membrane pores that are repaired within 20–80 seconds; even this short exposure is sufficient for delivery of lethal amounts of granzymes, with caspase-dependent apoptosis initiated within 2 minutes.","method":"Time-lapse live microscopy of immune synapse; biochemical Ca2+ flux and permeabilization assays; caspase activation assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — direct real-time visualization of pore formation kinetics in physiological immune synapse","pmids":["23377437"],"is_preprint":false},{"year":2012,"finding":"In a cohort of HLH patients with complete loss of perforin, Rab27a, or syntaxin-11, disease severity (age at onset) differed significantly with a gradient: perforin deficiency caused earliest onset, followed by Rab27a, then syntaxin-11. A syntaxin-11-deficient mouse model showed that HLH severity was not fully correlated with differences in cytotoxic activity but that antigen presentation capacity also differed, suggesting cytotoxic effectors have immune-regulatory roles beyond controlling viral replication.","method":"Patient cohort comparison; Stx11−/− mouse model with LCMV infection; lymphocyte degranulation assays; rescue with human STX11 expression","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in human patients plus matched mouse model with functional rescue","pmids":["23160464"],"is_preprint":false},{"year":2018,"finding":"miR-30e was shown to directly target PRF1 mRNA and negatively regulate perforin expression in peripheral blood NK cells and decidual NK cells; up-regulation of miR-30e suppressed NK cell cytotoxicity and shifted cytokine production toward IL-4/IL-10 (Th2) by reducing perforin levels, contributing to immune tolerance at the maternal-fetal interface.","method":"miRNA mimic/inhibitor transfection; PCR and Western blot for miR-30e and PRF1; flow cytometry for cytotoxicity and cytokine expression; ELISA","journal":"Biomedicine & Pharmacotherapy","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, target validation by transfection with multiple readouts but no direct luciferase reporter or AGO-pulldown","pmids":["30551399"],"is_preprint":false},{"year":2020,"finding":"In perforin-deficient mice, the tumor suppressive activity of GSDME was abrogated: GSDME expression in tumor cells normally promotes anti-tumor immunity via killer cytotoxic lymphocytes (NK and CD8+ T cells), and this function is lost when perforin is absent, demonstrating that perforin is required downstream of GSDME-mediated pyroptosis for anti-tumor immune activation. Additionally, granzyme B from killer cells directly cleaves GSDME at the same caspase-3 site to trigger caspase-independent pyroptosis in target cells.","method":"Perforin-deficient mouse tumor models; GSDME knockout/overexpression; granzyme B cleavage assays in vitro; lymphocyte depletion experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo genetic epistasis in KO mice plus in vitro cleavage assays, multiple orthogonal approaches","pmids":["32188940"],"is_preprint":false},{"year":2020,"finding":"CAR T cells activate caspase 3 in target cells through release of granzyme B, which cleaves gasdermin E (GSDME), triggering pyroptosis; the quantity of perforin/granzyme B released by CAR T cells (rather than conventional CD8+ T cells) is critical for inducing target cell pyroptosis and the subsequent cytokine release syndrome, defining perforin release level as a key determinant of pyroptosis-mediated CRS.","method":"CAR T cell co-culture assays; granzyme B measurement; GSDME knockout models; caspase inhibitor experiments; patient correlations","journal":"Science Immunology","confidence":"High","confidence_rationale":"Tier 2 — functional KO and mechanistic dissection in mouse models and patient samples","pmids":["31953257"],"is_preprint":false},{"year":2001,"finding":"Comprehensive mutational analysis of the PRF1 coding region in FHL patients identified missense, nonsense, and deletion mutations spread across the gene; the W374X nonsense mutation at codon 374 was identified as the most common perforin mutation, found in approximately 30% of Turkish FHL patients. All identified mutations associated with absent or severely reduced perforin in granules and absent NK/CTL cytotoxic activity, establishing genotype-phenotype correlations.","method":"Gene sequencing of all exons; NK cytotoxicity assays; immunostaining; linkage analysis","journal":"American Journal of Human Genetics","confidence":"High","confidence_rationale":"Tier 2 — large multi-patient genetic and functional study replicated across labs","pmids":["11179007"],"is_preprint":false},{"year":2006,"finding":"Missense mutations in RAB27A (Ala87Pro) and hMunc13-4/UNC13D (Leu403Pro) were shown to prevent formation of a stable hMunc13-4/Rab27a complex in vitro using a mammalian two-hybrid system, functionally characterizing these FHL-related missense mutations in the granule exocytosis pathway that delivers perforin to targets.","method":"Mammalian two-hybrid system; large-scale PRF1/UNC13D/STX11 sequencing; functional complex formation assay","journal":"Human Mutation","confidence":"Medium","confidence_rationale":"Tier 2 — functional two-hybrid assay for complex formation, large genetic study","pmids":["16278825"],"is_preprint":false},{"year":2012,"finding":"The PRF1 A91V missense mutation (compound heterozygous with G149S) was shown to result in low perforin expression levels and impaired NK cell-mediated cytotoxicity, which was partially reconstituted after incubation with IL-2, demonstrating that this hypomorphic mutation reduces but does not abolish perforin function and can predispose to later-onset FHL2.","method":"Flow cytometry for intracellular perforin; NK cell cytotoxicity assays; IL-2 stimulation rescue","journal":"Human Immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays in patient cells with IL-2 rescue experiment","pmids":["23073290"],"is_preprint":false},{"year":2016,"finding":"Missense perforin mutations A91V and R410W were shown to cause protein misfolding and partial loss of perforin activity, linking partial PRF1 loss-of-function to hereditary cancer predisposition including hematological malignancies and some solid tumors across three generations of a family.","method":"Sequencing; protein misfolding assessment; functional perforin activity assays; family pedigree analysis","journal":"Oncoimmunology","confidence":"Medium","confidence_rationale":"Tier 2–3 — functional misfolding and activity assays in single family","pmids":["27622035"],"is_preprint":false}],"current_model":"Perforin (PRF1) is a Ca2+-dependent pore-forming protein stored in cytotoxic granules of NK cells and CTLs that, upon target cell recognition, is exocytosed and binds target cell membranes via its C-terminal C2 domain, oligomerizes through its MACPF/CDC domain (oriented inside-out relative to CDCs) to form transmembrane pores (~160 Å), triggering Ca2+-dependent endocytosis of perforin-granzyme-serglycin complexes into gigantosomes from which perforin forms additional pores to release granzymes into the cytosol, ultimately inducing apoptosis or (via granzyme B cleavage of gasdermin E) pyroptosis in target cells; loss-of-function PRF1 mutations cause familial hemophagocytic lymphohistiocytosis type 2 (FHL2) by abolishing cytotoxic lymphocyte-mediated immune homeostasis, while hypomorphic mutations predispose to late-onset HLH, lymphoma, and autoimmunity."},"narrative":{"teleology":[{"year":1986,"claim":"Establishing the fundamental pore-forming activity: purified perforin was shown to form Ca²⁺-dependent ~160 Å transmembrane pores and large nonselective ion channels, providing the molecular basis for cytotoxic lymphocyte killing activity.","evidence":"Protein purification from cytolytic granules; planar lipid bilayer electrophysiology; liposome leakage; electron microscopy","pmids":["2420467","2425429"],"confidence":"High","gaps":["Mechanism of oligomerization and pore assembly unknown","In vivo relevance not yet demonstrated genetically","Lipid selectivity of membrane binding uncharacterized"]},{"year":1988,"claim":"Cloning human and mouse perforin cDNAs revealed homology to complement C9 in the MACPF domain, establishing that cytotoxic lymphocyte killing uses a pore-forming module shared with innate immunity and restricted to killer-type cells.","evidence":"cDNA cloning; RNA blot analysis; sequence comparison between perforin and C9","pmids":["3419519","3261391","2592021"],"confidence":"High","gaps":["Domain boundaries and three-dimensional structure unknown","No functional mutagenesis of homology region"]},{"year":1998,"claim":"Demonstrating that perforin functions beyond direct cytolysis: perforin was required to deliver granulysin into cells harboring intracellular M. tuberculosis, establishing its role as a general translocator for granule effectors in antimicrobial defense.","evidence":"CTL killing assays against intracellular M. tuberculosis; granulysin-dependent and perforin-dependent killing reconstitution","pmids":["9756476"],"confidence":"High","gaps":["Mechanism of intracellular delivery to pathogen-containing compartments unresolved","Relative contributions of perforin pore vs. endosomal pathway for granulysin delivery unknown"]},{"year":1999,"claim":"Identifying perforin deficiency as the genetic cause of familial hemophagocytic lymphohistiocytosis type 2 established that perforin-mediated cytotoxicity is essential for immune homeostasis, not just pathogen clearance.","evidence":"PRF1 gene sequencing in FHL families; absent perforin immunostaining; defective NK/CTL cytotoxicity","pmids":["10583959","11179007"],"confidence":"High","gaps":["Precise mechanism by which perforin deficiency triggers hyperinflammation not defined","Genotype-phenotype spectrum for hypomorphic alleles incomplete"]},{"year":2000,"claim":"Perforin-deficient mice showed uncontrolled CD8⁺ T cell expansion after infection, revealing that perforin regulates lymphocyte homeostasis through a mechanism independent of its antimicrobial role, explaining the immunoregulatory failure in FHL.","evidence":"Perforin-KO mice infected with Listeria monocytogenes; flow cytometry tracking antigen-specific CD8⁺ T cells","pmids":["11082062"],"confidence":"High","gaps":["Whether perforin acts on T cells directly (fratricide) or through APC killing is unresolved","Relative importance of this pathway vs. Fas/FasL in vivo uncertain"]},{"year":2002,"claim":"Demonstrating that granzyme B, perforin, and serglycin exist as preformed macromolecular complexes in granules resolved how effector molecules are co-delivered: serglycin serves as a scaffold, perforin as translocator, and granzyme B as the apoptotic effector.","evidence":"Co-immunoprecipitation; gel filtration; cytotoxicity and membrane permeabilization assays","pmids":["11911826"],"confidence":"High","gaps":["Stoichiometry of the complex undefined","Whether serglycin is required for pore formation in vivo unknown"]},{"year":2010,"claim":"The crystal structure of monomeric perforin and cryo-EM reconstruction of the pore revealed that the MACPF domain is oriented inside-out relative to CDCs, the C2 domain mediates Ca²⁺-dependent membrane docking, and >50 FHL mutations mapped onto the structure, providing the first atomic framework for understanding disease and pore assembly.","evidence":"X-ray crystallography of murine perforin; cryo-EM pore reconstruction; mapping of FHL mutations","pmids":["21037563"],"confidence":"High","gaps":["High-resolution pore structure at near-atomic resolution not yet achieved","Conformational intermediates during oligomerization unresolved"]},{"year":2011,"claim":"Live-cell imaging revealed a two-step delivery mechanism: perforin pores at the plasma membrane trigger Ca²⁺-dependent endocytosis of perforin–granzyme complexes into gigantosomes, from which secondary perforin pores release granzymes into the cytosol, resolving the long-standing question of how granzymes access cytosolic substrates.","evidence":"Live-cell time-lapse microscopy; Ca²⁺ flux measurements; endosomal fractionation; fluorescent granzyme tracking","pmids":["21685908","20530211"],"confidence":"High","gaps":["Molecular signals governing gigantosome formation incompletely defined","Role of acid sphingomyelinase pathway in vivo during CTL attack not confirmed"]},{"year":2013,"claim":"Real-time imaging at the immune synapse showed perforin pores assemble within 30 seconds and are repaired within 20–80 seconds, yet this window suffices for lethal granzyme delivery and caspase activation within 2 minutes, defining the kinetic constraints of the killing mechanism.","evidence":"Time-lapse microscopy of immune synapse; biochemical permeabilization and caspase activation assays in primary human CTLs","pmids":["23377437"],"confidence":"High","gaps":["Whether pore repair is target cell type-dependent unknown","Contribution of endosomal vs. direct plasma membrane pathway in this rapid killing not quantified"]},{"year":2020,"claim":"Perforin was shown to be required for granzyme B–mediated cleavage of gasdermin E in target cells, linking the perforin pathway to pyroptosis (not only apoptosis) and establishing perforin release levels as a determinant of pyroptosis-driven cytokine release syndrome in CAR T cell therapy.","evidence":"Perforin-KO mouse tumor models; GSDME knockout; granzyme B cleavage assays; CAR T cell co-culture with caspase inhibitors","pmids":["32188940","31953257"],"confidence":"High","gaps":["Whether perforin pores are needed for GSDME cleavage in all tumor types unresolved","Therapeutic strategies to modulate perforin release for CRS mitigation not established"]},{"year":null,"claim":"A near-atomic resolution structure of the full perforin pore, the conformational pathway from monomer to assembled ring, and the precise mechanism by which perforin selectively spares the effector CTL/NK cell remain major unresolved questions.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution cryo-EM pore structure at near-atomic resolution","Self-protection mechanism of killer cells not molecularly defined","Relative quantitative contributions of direct plasma membrane pore vs. endosomal pathway in different target cell types unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,9]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,9]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,11]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,8]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[8,12]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,9,11]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,5,6,7,15,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,12,15,16]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,17,20]}],"complexes":["Granzyme B–serglycin–perforin granule complex"],"partners":["GZMB","SRGN","GSDME","GNLY"],"other_free_text":[]},"mechanistic_narrative":"Perforin-1 (PRF1) is a Ca²⁺-dependent pore-forming protein of cytotoxic lymphocytes that serves as the essential membrane-disrupting effector enabling granzyme delivery to target cells, thereby mediating immune killing and lymphocyte homeostasis. Stored in cytotoxic granules as part of macromolecular complexes with granzyme B and serglycin, perforin is exocytosed at the immune synapse, where its C-terminal C2 domain binds target membranes in a Ca²⁺-dependent manner and its MACPF/CDC domain oligomerizes to form ~160 Å transmembrane pores; these pores trigger Ca²⁺-dependent endocytosis of granzyme–serglycin complexes into enlarged endosomes (\"gigantosomes\"), from which perforin forms secondary pores to release granzymes into the cytosol, initiating apoptosis or, through granzyme B cleavage of gasdermin E, pyroptosis [PMID:2420467, PMID:21037563, PMID:11911826, PMID:21685908, PMID:32188940]. Loss-of-function PRF1 mutations cause familial hemophagocytic lymphohistiocytosis type 2 (FHL2), while hypomorphic mutations such as A91V predispose to late-onset HLH and hematological malignancies [PMID:10583959, PMID:11179007, PMID:27622035]. Perforin also controls CD8⁺ T cell homeostasis independently of its antimicrobial effector role and cooperates with granulysin to kill intracellular Mycobacterium tuberculosis [PMID:11082062, PMID:9756476]."},"prefetch_data":{"uniprot":{"accession":"P14222","full_name":"Perforin-1","aliases":["Cytolysin","Lymphocyte pore-forming protein","PFP"],"length_aa":555,"mass_kda":61.4,"function":"Pore-forming protein that plays a key role in granzyme-mediated programmed cell death, and in defense against virus-infected or neoplastic cells (PubMed:20889983, PubMed:21037563, PubMed:24558045, PubMed:9058810, PubMed:9164947). Plays an important role in killing other cells that are recognized as non-self by the immune system, e.g. in transplant rejection or some forms of autoimmune disease (PubMed:9058810). Can insert into the membrane of target cells in its calcium-bound form, oligomerize and form large pores (PubMed:20889983, PubMed:21037563). Promotes cytolysis and apoptosis of target cells by mediating the passage and uptake of cytotoxic granzymes (PubMed:20038786, PubMed:20225066, PubMed:24558045, PubMed:32299851). Facilitates the delivery of cationic cargo protein, while anionic or neural proteins are not delivered efficiently (PubMed:24558045). Perforin pores allow the release of mature caspase-7 (CASP7) into the extracellular milieu (By similarity)","subcellular_location":"Cytolytic granule; Secreted; Cell membrane; Endosome lumen","url":"https://www.uniprot.org/uniprotkb/P14222/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PRF1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PRF1","total_profiled":1310},"omim":[{"mim_id":"618477","title":"URIDINE-CYTIDINEURIA; URCTU","url":"https://www.omim.org/entry/618477"},{"mim_id":"615122","title":"LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2","url":"https://www.omim.org/entry/615122"},{"mim_id":"613562","title":"Fc RECEPTOR-LIKE PROTEIN 6; FCRL6","url":"https://www.omim.org/entry/613562"},{"mim_id":"613101","title":"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE; FHL5","url":"https://www.omim.org/entry/613101"},{"mim_id":"612880","title":"SYNAPTOTAGMIN-LIKE 2; SYTL2","url":"https://www.omim.org/entry/612880"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":26.9},{"tissue":"lung","ntpm":15.5},{"tissue":"lymphoid tissue","ntpm":46.4}],"url":"https://www.proteinatlas.org/search/PRF1"},"hgnc":{"alias_symbol":["PFP","P1","HPLH2"],"prev_symbol":[]},"alphafold":{"accession":"P14222","domains":[{"cath_id":"-","chopping":"97-372_547-554","consensus_level":"medium","plddt":91.6826,"start":97,"end":554},{"cath_id":"2.60.40.150","chopping":"415-535","consensus_level":"high","plddt":94.4531,"start":415,"end":535}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14222","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14222-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14222-F1-predicted_aligned_error_v6.png","plddt_mean":90.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PRF1","jax_strain_url":"https://www.jax.org/strain/search?query=PRF1"},"sequence":{"accession":"P14222","fasta_url":"https://rest.uniprot.org/uniprotkb/P14222.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14222/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14222"}},"corpus_meta":[{"pmid":"12074568","id":"PMC_12074568","title":"The P1' specificity of tobacco etch virus protease.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12074568","citation_count":330,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21881043","id":"PMC_21881043","title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21881043","citation_count":318,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15489417","id":"PMC_15489417","title":"Genome of bacteriophage P1.","date":"2004","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/15489417","citation_count":225,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2904838","id":"PMC_2904838","title":"An Ultrabithorax protein binds sequences near its own and the Antennapedia P1 promoters.","date":"1988","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2904838","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8882583","id":"PMC_8882583","title":"The role of MCM/P1 proteins in the licensing of DNA replication.","date":"1996","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/8882583","citation_count":159,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10064607","id":"PMC_10064607","title":"P1 ParA interacts with the P1 partition complex at parS and an ATP-ADP switch controls ParA activities.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10064607","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3119495","id":"PMC_3119495","title":"Cloning and sequence analysis of cytadhesin P1 gene from Mycoplasma pneumoniae.","date":"1987","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/3119495","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21586362","id":"PMC_21586362","title":"Impact of ectoenzymes on p2 and p1 receptor signaling.","date":"2011","source":"Advances in pharmacology (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/21586362","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10611311","id":"PMC_10611311","title":"Intracellular localization of P1 ParB protein depends on ParA and parS.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10611311","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10402430","id":"PMC_10402430","title":"Environmental signals controlling sexual development of the corn Smut fungus Ustilago maydis through the transcriptional regulator Prf1.","date":"1999","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/10402430","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9829946","id":"PMC_9829946","title":"Corepression of the P1 addiction operon by Phd and Doc.","date":"1998","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/9829946","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18655063","id":"PMC_18655063","title":"PFP: Automated prediction of gene ontology functional annotations with confidence scores using protein sequence data.","date":"2009","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/18655063","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"325389","id":"PMC_325389","title":"Replication of prophage P1 during the cell cycle of Escherichia coli.","date":"1977","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/325389","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3029954","id":"PMC_3029954","title":"Two DNA antirestriction systems of bacteriophage P1, darA, and darB: characterization of darA- phages.","date":"1987","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/3029954","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14592979","id":"PMC_14592979","title":"PKA and MAPK phosphorylation of Prf1 allows promoter discrimination in Ustilago maydis.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14592979","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15090541","id":"PMC_15090541","title":"PTEN regulates Mdm2 expression through the P1 promoter.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15090541","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12225754","id":"PMC_12225754","title":"Solution structure of a luteoviral P1-P2 frameshifting mRNA pseudoknot.","date":"2002","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12225754","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18710388","id":"PMC_18710388","title":"Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/18710388","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"4193834","id":"PMC_4193834","title":"Morphological variants of coliphage P1.","date":"1970","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/4193834","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23160464","id":"PMC_23160464","title":"Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23160464","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10746778","id":"PMC_10746778","title":"Proteins complexed to the P1 adhesin of Mycoplasma pneumoniae.","date":"2000","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10746778","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6340741","id":"PMC_6340741","title":"The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases.","date":"1983","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6340741","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2592021","id":"PMC_2592021","title":"Molecular cloning and chromosomal assignment of a human perforin (PFP) gene.","date":"1989","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/2592021","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3676400","id":"PMC_3676400","title":"Both P1 and P2 protamine genes are expressed in mouse, hamster, and rat.","date":"1987","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/3676400","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18705848","id":"PMC_18705848","title":"Host-specific effect of P1 exchange between two potyviruses.","date":"2008","source":"Molecular plant pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18705848","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11340190","id":"PMC_11340190","title":"Small changes in the regulation of one Arabidopsis profilin isovariant, PRF1, alter seedling development.","date":"2001","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/11340190","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25671413","id":"PMC_25671413","title":"Binding forces of Streptococcus mutans P1 adhesin.","date":"2015","source":"ACS nano","url":"https://pubmed.ncbi.nlm.nih.gov/25671413","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11866514","id":"PMC_11866514","title":"Architecture of Fis-activated transcription complexes at the Escherichia coli rrnB P1 and rrnE P1 promoters.","date":"2002","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11866514","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20179875","id":"PMC_20179875","title":"Micrococcin P1: structure, biology and synthesis.","date":"2010","source":"Natural product reports","url":"https://pubmed.ncbi.nlm.nih.gov/20179875","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7669337","id":"PMC_7669337","title":"The tripartite immunity system of phages P1 and P7.","date":"1995","source":"FEMS microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/7669337","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28798419","id":"PMC_28798419","title":"DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28798419","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26993329","id":"PMC_26993329","title":"Pyrophosphate: fructose-6-phosphate 1-phosphotransferase (PFP) regulates carbon metabolism during grain filling in rice.","date":"2016","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26993329","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21091504","id":"PMC_21091504","title":"Partitioning of P1 plasmids by gradual distribution of the ATPase ParA.","date":"2010","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21091504","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24385927","id":"PMC_24385927","title":"The PAF complex and Prf1/Rtf1 delineate distinct Cdk9-dependent pathways regulating transcription elongation in fission yeast.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24385927","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1696181","id":"PMC_1696181","title":"The c4 repressors of bacteriophages P1 and P7 are antisense RNAs.","date":"1990","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1696181","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8576044","id":"PMC_8576044","title":"Three functions of bacteriophage P1 involved in cell lysis.","date":"1996","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8576044","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28509398","id":"PMC_28509398","title":"The multicomponent antirestriction system of phage P1 is linked to capsid morphogenesis.","date":"2017","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28509398","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2826133","id":"PMC_2826133","title":"P1 plasmid replication requires methylated DNA.","date":"1987","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2826133","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21674762","id":"PMC_21674762","title":"Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.","date":"2011","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21674762","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26184781","id":"PMC_26184781","title":"Spectrum of Atypical Clinical Presentations in Patients with Biallelic PRF1 Missense Mutations.","date":"2015","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26184781","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8428967","id":"PMC_8428967","title":"Linkage of human spermatid-specific basic nuclear protein genes. Definition and evolution of the P1-->P2-->TP2 locus.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8428967","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11779232","id":"PMC_11779232","title":"Loop-inserted and thermostabilized structure of P1-P1' cleaved ovalbumin mutant R339T.","date":"2002","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11779232","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6724135","id":"PMC_6724135","title":"Stimulation of DNA synthesis by microinjection of diadenosine 5',5''-P1, P4-tetraphosphate (Ap4A) into Xenopus laevis oocytes.","date":"1984","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/6724135","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9425114","id":"PMC_9425114","title":"Cloning and expression of diadenosine 5',5'''-P1,P4-tetraphosphate hydrolase from Lupinus angustifolius L.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9425114","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12435115","id":"PMC_12435115","title":"Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans.","date":"2002","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12435115","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2556364","id":"PMC_2556364","title":"Isolation, characterization, and inactivation of the APA1 gene encoding yeast diadenosine 5',5'''-P1,P4-tetraphosphate phosphorylase.","date":"1989","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2556364","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21451259","id":"PMC_21451259","title":"P1 peptidase--a mysterious protein of family Potyviridae.","date":"2011","source":"Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21451259","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30165572","id":"PMC_30165572","title":"Phylo-PFP: improved automated protein function prediction using phylogenetic distance of distantly related sequences.","date":"2019","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30165572","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8550409","id":"PMC_8550409","title":"Characterization and phylogeny of the pfp gene of Amycolatopsis methanolica encoding PPi-dependent phosphofructokinase.","date":"1996","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/8550409","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15701800","id":"PMC_15701800","title":"The high-mobility-group domain transcription factor Rop1 is a direct regulator of prf1 in Ustilago maydis.","date":"2005","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/15701800","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18627457","id":"PMC_18627457","title":"Pheromone-regulated target genes respond differentially to MAPK phosphorylation of transcription factor Prf1.","date":"2008","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/18627457","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21258434","id":"PMC_21258434","title":"Uptake of Hydrocarbon by Pseudomonas fluorescens (P1) and Pseudomonas putida (K1) Strains in the Presence of Surfactants: A Cell Surface Modification.","date":"2010","source":"Water, air, and soil pollution","url":"https://pubmed.ncbi.nlm.nih.gov/21258434","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33065270","id":"PMC_33065270","title":"A Pd1-Ps-P1 Feedback Loop Controls Pubescence Density in Soybean.","date":"2020","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/33065270","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8024562","id":"PMC_8024562","title":"Interaction of human P1 and P2 protamines with DNA.","date":"1994","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8024562","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16860143","id":"PMC_16860143","title":"Patients of African ancestry with hemophagocytic lymphohistiocytosis share a common haplotype of PRF1 with a 50delT mutation.","date":"2006","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/16860143","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1696317","id":"PMC_1696317","title":"Structure of the ecdysone-inducible P1 gene of Drosophila melanogaster.","date":"1990","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1696317","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2763457","id":"PMC_2763457","title":"The superimmunity gene sim of bacteriophage P1 causes superinfection exclusion.","date":"1989","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/2763457","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30551399","id":"PMC_30551399","title":"Effect of miR-30e regulating NK cell activities on immune tolerance of maternal-fetal interface by targeting PRF1.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30551399","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26901859","id":"PMC_26901859","title":"Transcriptional Auto-Regulation of RUNX1 P1 Promoter.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26901859","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2536753","id":"PMC_2536753","title":"Three additional operators, Op21, Op68, and Op88, of bacteriophage P1. Evidence for control of the P1 dam methylase by Op68.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2536753","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33566725","id":"PMC_33566725","title":"PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity.","date":"2020","source":"Multiple sclerosis (Houndmills, Basingstoke, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33566725","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17038498","id":"PMC_17038498","title":"Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17038498","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3990691","id":"PMC_3990691","title":"Transfection by genomic DNA of cytochrome P1-450 enzymatic activity and inducibility.","date":"1985","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3990691","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21070949","id":"PMC_21070949","title":"Phosphorylation of DCC by ERK2 is facilitated by direct docking of the receptor P1 domain to the kinase.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/21070949","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18249539","id":"PMC_18249539","title":"BACE1 inhibitors: optimization by replacing the P1' residue with non-acidic moiety.","date":"2008","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/18249539","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19400774","id":"PMC_19400774","title":"Hap2 regulates the pheromone response transcription factor prf1 in Ustilago maydis.","date":"2009","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19400774","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1459462","id":"PMC_1459462","title":"Transcriptional control via translational repression by c4 antisense RNA of bacteriophages P1 and P7.","date":"1992","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/1459462","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37907681","id":"PMC_37907681","title":"Domain-PFP allows protein function prediction using function-aware domain embedding representations.","date":"2023","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/37907681","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25273111","id":"PMC_25273111","title":"PFP/ESG: automated protein function prediction servers enhanced with Gene Ontology visualization tool.","date":"2014","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25273111","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30778365","id":"PMC_30778365","title":"Morphological Changes and Expressions of AOX1A, CYP81D8, and Putative PFP Genes in a Large Set of Commercial Maize Hybrids Under Extreme Waterlogging.","date":"2019","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/30778365","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18362133","id":"PMC_18362133","title":"Requirements for surface expression and function of adhesin P1 from Streptococcus mutans.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18362133","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27622035","id":"PMC_27622035","title":"Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition.","date":"2016","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/27622035","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1740459","id":"PMC_1740459","title":"C1 repressor of phage P1 is inactivated by noncovalent binding of P1 Coi protein.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1740459","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16789200","id":"PMC_16789200","title":"Mutations in coliphage p1 affecting host cell lysis.","date":"1980","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16789200","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11322826","id":"PMC_11322826","title":"Complete nucleotide sequence of the mycoplasma virus P1 genome.","date":"2001","source":"Plasmid","url":"https://pubmed.ncbi.nlm.nih.gov/11322826","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2826478","id":"PMC_2826478","title":"The c1 repressor of bacteriophage P1. Isolation and characterization of the repressor protein.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2826478","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2585500","id":"PMC_2585500","title":"Organization of the immunity region immI of bacteriophage P1 and synthesis of the P1 antirepressor.","date":"1989","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2585500","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2644199","id":"PMC_2644199","title":"Protein-DNA interactions in regulation of P1 plasmid replication.","date":"1989","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2644199","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18524693","id":"PMC_18524693","title":"P1 nuclease cleavage is dependent on length of the mismatches in DNA.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18524693","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12379671","id":"PMC_12379671","title":"Neisseria gonorrhoeae porin P1.B induces endosome exocytosis and a redistribution of Lamp1 to the plasma membrane.","date":"2002","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12379671","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9093834","id":"PMC_9093834","title":"Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.","date":"1997","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9093834","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29555351","id":"PMC_29555351","title":"Mycoplasma pneumoniae induces allergy by producing P1-specific immunoglobulin E.","date":"2018","source":"Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29555351","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12504798","id":"PMC_12504798","title":"The involvement of diadenosine 5',5\"'-P1,P4-tetraphosphate in cell cycle arrest and regulation of apoptosis.","date":"2003","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12504798","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7981226","id":"PMC_7981226","title":"Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.","date":"1994","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7981226","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23173871","id":"PMC_23173871","title":"Evaluation of function predictions by PFP, ESG,and PSI-BLAST for moonlighting proteins.","date":"2012","source":"BMC proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/23173871","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16038932","id":"PMC_16038932","title":"Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16038932","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26922829","id":"PMC_26922829","title":"Collectin CL-P1 utilizes C-reactive protein for complement activation.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26922829","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7774927","id":"PMC_7774927","title":"A YAC-, P1-, and cosmid-based physical map of the BRCA1 region on chromosome 17q21.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7774927","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32194620","id":"PMC_32194620","title":"Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32194620","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23073290","id":"PMC_23073290","title":"Functional impact of A91V mutation of the PRF1 perforin gene.","date":"2012","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23073290","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2155832","id":"PMC_2155832","title":"Reductive trapping of substrate to methylamine oxidase from Arthrobacter P1.","date":"1990","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/2155832","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35458408","id":"PMC_35458408","title":"New Insights into the Structure and Assembly of Bacteriophage P1.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/35458408","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2211715","id":"PMC_2211715","title":"A bacteriophage P1-encoded modulator protein affects the P1 c1 repression system.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2211715","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6223918","id":"PMC_6223918","title":"SOS induction by P1 Km miniplasmids.","date":"1983","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/6223918","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22986680","id":"PMC_22986680","title":"Paramutagenicity of a p1 epiallele in maize.","date":"2012","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/22986680","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25774339","id":"PMC_25774339","title":"MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer.","date":"2015","source":"Current pharmacology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25774339","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2526777","id":"PMC_2526777","title":"Organization of the bacteriophage P1 tail-fibre operon.","date":"1989","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/2526777","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24232685","id":"PMC_24232685","title":"Increased capsaicin content in PFP-resistant cells of chili pepper (Capsicum annuum L.).","date":"1990","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24232685","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9131417","id":"PMC_9131417","title":"P1-purinoceptor-mediated vasodilatation and vasoconstriction in hypoxia.","date":"1996","source":"Journal of autonomic pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9131417","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24578718","id":"PMC_24578718","title":"A novel PRF1 gene mutation in a fatal neonate case with type 2 familial hemophagocytic lymphohistiocytosis.","date":"2014","source":"Korean journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/24578718","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32188940","id":"PMC_32188940","title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32188940","citation_count":1315,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10583959","id":"PMC_10583959","title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10583959","citation_count":940,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12368910","id":"PMC_12368910","title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.","date":"2002","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12368910","citation_count":835,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9756476","id":"PMC_9756476","title":"An antimicrobial activity of cytolytic T cells mediated by granulysin.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9756476","citation_count":791,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31953257","id":"PMC_31953257","title":"Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31953257","citation_count":469,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3419519","id":"PMC_3419519","title":"Structure and function of human perforin.","date":"1988","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3419519","citation_count":354,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2420467","id":"PMC_2420467","title":"Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.","date":"1986","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2420467","citation_count":345,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11082062","id":"PMC_11082062","title":"Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11082062","citation_count":334,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21037563","id":"PMC_21037563","title":"The structural basis for membrane binding and pore formation by lymphocyte perforin.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21037563","citation_count":324,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20530211","id":"PMC_20530211","title":"Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair.","date":"2010","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20530211","citation_count":290,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2425429","id":"PMC_2425429","title":"The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.","date":"1986","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2425429","citation_count":281,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20523897","id":"PMC_20523897","title":"Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20523897","citation_count":270,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3261391","id":"PMC_3261391","title":"Homology of perforin to the ninth component of complement (C9).","date":"1988","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3261391","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21685908","id":"PMC_21685908","title":"Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells.","date":"2011","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21685908","citation_count":240,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16278825","id":"PMC_16278825","title":"Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A.","date":"2006","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16278825","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17703412","id":"PMC_17703412","title":"Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.","date":"2007","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17703412","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11911826","id":"PMC_11911826","title":"Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation.","date":"2002","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11911826","citation_count":208,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23377437","id":"PMC_23377437","title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23377437","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11179007","id":"PMC_11179007","title":"Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11179007","citation_count":195,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15641052","id":"PMC_15641052","title":"Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.","date":"2005","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15641052","citation_count":193,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"37198476","id":"PMC_37198476","title":"Structural basis of NINJ1-mediated plasma membrane rupture in cell death.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37198476","citation_count":191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20019066","id":"PMC_20019066","title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.","date":"2009","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20019066","citation_count":183,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42511,"output_tokens":2205,"usd":0.080304},"stage2":{"model":"claude-opus-4-6","input_tokens":5025,"output_tokens":2025,"usd":0.113625},"total_usd":0.501585,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":55079,"output_tokens":6278,"usd":0.129703},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8987,"output_tokens":2948,"usd":0.177953}},"stage1_raw":"Looking at the corpus, I need to identify papers about human/mammalian PRF1 (perforin), a pore-forming protein essential for lymphocyte cytotoxicity. Most papers in this corpus are about completely unrelated genes that share \"P1\" in their names (bacteriophage P1, Mycoplasma P1 adhesin, plant profilin PRF1, Ustilago Prf1 transcription factor, protamine P1, etc.). I need to focus only on the mammalian perforin gene PRF1.\n\nRelevant papers about human/mammalian perforin PRF1:\n- PMID:2592021 - Molecular cloning and chromosomal assignment of human perforin (PFP) gene\n- PMID:21881043 - Hypomorphic mutations in PRF1 associated with adult-onset HLH\n- PMID:18710388 - PRF1, STX11, UNC13D genotype-phenotype correlations in FHL\n- PMID:23160464 - Distinct severity of HLH with complete loss of PRF1, RAB27A, STX11\n- PMID:26184781 - Spectrum of atypical presentations with biallelic PRF1 missense mutations\n- PMID:30551399 - miR-30e targeting PRF1 in NK cells\n- PMID:27622035 - Missense mutations in PRF1 as hereditary cancer predisposition\n- PMID:23073290 - Functional impact of A91V mutation of PRF1\n- PMID:16860143 - African ancestry HLH patients share PRF1 haplotype with 50delT mutation\n- PMID:33566725 - PRF1 mutation alters immune system activation\n\nFrom these, the mechanistic findings are limited but present.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"Human perforin (PRF1/PFP) was cloned and sequenced, revealing a protein with 68.4% similarity to mouse perforin; expression was shown to be preferentially restricted to killer-type cell lines and large granular lymphocytes, and the gene was localized to chromosome 17q11-21 by in situ hybridization.\",\n      \"method\": \"cDNA cloning, RNA blot analysis, in situ hybridization\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cloning and expression analysis with chromosomal mapping; single study but multiple methods\",\n      \"pmids\": [\"2592021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Complete loss of perforin (PRF1) in human patients produced the earliest onset and most severe form of hemophagocytic lymphohistiocytosis (HLH) compared to complete loss of RAB27A or STX11, establishing perforin as the most critical cytotoxic effector in this pathway; perforin-deficient mouse lymphocytes showed the most severe HLH phenotype after LCMV infection, confirming a severity gradient: perforin > Rab27a > syntaxin-11.\",\n      \"method\": \"Genetic loss-of-function patient cohort analysis combined with murine knockout models (Stx11-/- mice) challenged with LCMV infection; degranulation rescue experiments with human syntaxin-11 expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — orthogonal human genetic and murine KO data with defined phenotypic readout, replicated across species\",\n      \"pmids\": [\"23160464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hypomorphic (missense and splice-site) mutations in PRF1 cause adult-onset familial HLH, with the A91V-PRF1 genotype being the most common, demonstrating that partial loss of perforin function leads to a later-onset, more indolent cytotoxicity defect compared to null mutations.\",\n      \"method\": \"Retrospective genetic sequencing of PRF1 in adult HLH patients; immunological testing of cytotoxic function\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — large patient cohort with genetic and immunological data, single study\",\n      \"pmids\": [\"21881043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The A91V missense mutation in PRF1 results in reduced perforin protein expression and impaired NK cell-mediated cytotoxicity in a compound heterozygous individual (A91V/G149S), with partial reconstitution of cytotoxicity after IL-2 stimulation, demonstrating that A91V is a hypomorphic allele that partially reduces perforin function.\",\n      \"method\": \"Flow cytometry for intracellular perforin expression; NK cell cytotoxicity assays with and without IL-2 stimulation\",\n      \"journal\": \"Human immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assays on patient cells with two orthogonal methods, single lab\",\n      \"pmids\": [\"23073290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Two missense PRF1 mutations (A91V, R410W) cause protein misfolding and partial loss of perforin activity, linking partial perforin deficiency to hereditary cancer predisposition including haematological and solid tumors across three generations of a family.\",\n      \"method\": \"Family genetic analysis; functional assays demonstrating protein misfolding and partial loss of cytotoxic activity\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and functional evidence in patient-derived material, single study\",\n      \"pmids\": [\"27622035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-30e negatively regulates PRF1 expression in NK cells by directly targeting the PRF1 3'UTR; overexpression of miR-30e suppresses NK cell cytotoxicity and shifts cytokine secretion toward a Th2 profile (increased IL-4, IL-10; decreased IFN-γ, TNF-α), while miR-30e inhibition reverses these effects.\",\n      \"method\": \"Luciferase reporter assay confirming PRF1 as miR-30e target; miR-30e mimic/inhibitor transfection in NK cells; flow cytometry for surface receptors; cytotoxicity assay; PCR and Western blot for PRF1 expression\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct target validation with reporter assay and functional consequence in NK cells; single lab, multiple methods\",\n      \"pmids\": [\"30551399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Biallelic PRF1 missense mutations produce partial loss of perforin function (as evidenced by partial recovery of NK cytotoxicity with IL-2 stimulation in vitro) and are associated with a wide spectrum of atypical disease manifestations beyond classical HLH, including Hodgkin lymphoma, systemic lupus erythematosus, neurological disease, and gastrointestinal inflammation, indicating that residual perforin activity modulates disease phenotype.\",\n      \"method\": \"Retrospective patient cohort review; NK cell cytotoxicity assays with IL-2 stimulation; genotype-phenotype correlation\",\n      \"journal\": \"Pediatric blood & cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — clinical cohort with functional assays, no direct mechanistic reconstitution\",\n      \"pmids\": [\"26184781\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PRF1 encodes perforin, a pore-forming protein expressed in cytotoxic lymphocytes (NK cells and CTLs) that is essential for granule-dependent cytotoxicity; complete loss of perforin causes the earliest and most severe form of familial hemophagocytic lymphohistiocytosis (placing perforin as the most critical effector in the cytotoxic pathway, upstream of RAB27A and STX11), hypomorphic missense mutations (e.g., A91V) reduce protein expression and partially impair cytotoxic activity leading to later-onset disease and cancer predisposition, and perforin expression is post-transcriptionally regulated by miR-30e targeting its 3'UTR in NK cells.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper, then extract mechanistic discoveries only from KEEP papers about PRF1 (perforin, the pore-forming protein of cytotoxic lymphocytes).\n\n**Classification summary:**\n- KEEP: Papers about perforin (PRF1) - the cytolytic pore-forming protein of NK cells/CTLs\n- EXCLUDE: Papers about bacteriophage P1, Mycoplasma P1 adhesin, Ustilago Prf1 transcription factor, plant PRF1 profilin, protamine P1, purinoceptor P1, PFP phosphofructokinase, TEV protease P1 site, bioinformatics PFP tools, various other P1/PFP symbols\n\n**KEPT papers:**\n- PMID:10583959 (perforin gene defects in FHL)\n- PMID:3419519 (structure/function human perforin)\n- PMID:2420467 (purification/characterization PFP)\n- PMID:21037563 (crystal structure + cryo-EM of perforin pore)\n- PMID:2425429 (homology perforin to C9)\n- PMID:3261391 (homology perforin to C9, cDNA)\n- PMID:2592021 (molecular cloning human PFP gene)\n- PMID:21685908 (perforin pores in endosomal membrane)\n- PMID:23377437 (perforin forms transient pores)\n- PMID:11911826 (granzyme B-serglycin complexes, perforin delivery)\n- PMID:11082062 (regulation of CD8+ T cell homeostasis by perforin)\n- PMID:12368910 (HIV-specific CD8+ T cells, perforin expression)\n- PMID:20523897 (perforin expression ex vivo, HIV elite control)\n- PMID:9756476 (granulysin + perforin kill intracellular M. tuberculosis)\n- PMID:20019066 (PRF1 mutations in MAS/SoJIA)\n- PMID:21881043 (hypomorphic PRF1 mutations, adult HLH)\n- PMID:18710388 (PRF1/STX11/UNC13D genotype-phenotype)\n- PMID:16278825 (mutation spectrum PRF1/UNC13D/STX11/RAB27A)\n- PMID:11179007 (spectrum of perforin mutations in FHL)\n- PMID:23160464 (severity of HLH, perforin vs Rab27a vs STX11)\n- PMID:15641052 (perforin/granzyme B in SLE CD8+ T cells)\n- PMID:27622035 (PRF1 missense mutations, cancer predisposition)\n- PMID:16860143 (50delT PRF1 mutation haplotype)\n- PMID:21674762 (PRF1/UNC13D mutations in EBV-HLH)\n- PMID:26184781 (atypical presentations biallelic PRF1 missense)\n- PMID:23073290 (A91V PRF1 functional impact)\n- PMID:33566725 (PRF1 A91V mutation, immune activation)\n- PMID:30551399 (miR-30e targets PRF1 in NK cells)\n- PMID:24578718 (novel PRF1 mutation, FHL2 neonate)\n- PMID:32194620 (neurologic manifestations FHL2, PRF1 mutations)\n- PMID:32188940 (GSDME, perforin-deficient mice, tumor suppression)\n- PMID:31953257 (granzyme B, perforin, GSDME, CAR T cells)\n- PMID:20530211 (acid sphingomyelinase, membrane repair after perforin wounding)\n- PMID:16169070 (human PPI network - PRF1 interactions)\n- PMID:25416956 (proteome-scale interactome)\n- PMID:32296183 (HuRI reference interactome)\n- PMID:33961781 (BioPlex interactome)\n\nNow extracting only mechanistic discoveries:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1986,\n      \"finding\": \"Perforin (PFP) was purified from granules of cloned NK-like cytolytic cells and shown to form Ca2+-dependent transmembrane pores of ~160 Å diameter in target cell membranes, depolarizing cells and making lipid vesicles leaky; the protein formed large (averaging ~400 pS), voltage-insensitive, nonselective ion channels in planar bilayers, functionally and morphologically similar to lesions formed by intact NK cells.\",\n      \"method\": \"Protein purification from cytolytic granules; planar lipid bilayer electrophysiology; liposome leakage assays; electron microscopy of membrane lesions\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in vitro with purified protein, multiple orthogonal methods, foundational discovery\",\n      \"pmids\": [\"2420467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"Structural and functional homologies between perforin (PFP) and complement component C9 were demonstrated: monospecific antibodies to purified C9 and PFP showed cross-reactivity, and both proteins polymerize to form tubular membrane lesions (100 Å for C9, 160 Å for PFP) that create stable, nonselective, voltage-insensitive aqueous pores; perforin polymerization requires Ca2+.\",\n      \"method\": \"Immunological cross-reactivity assays; electron microscopy; planar lipid bilayer electrophysiology; Zn2+-induced polymerization of C9\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical reconstitution and structural comparison, replicated across labs\",\n      \"pmids\": [\"2425429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Human perforin cDNA was isolated; the deduced amino acid sequence showed 68.4% similarity to mouse perforin and confirmed structural homology to complement component C9 at functionally conserved regions; perforin expression was restricted to killer-type cells (NK cells and cytotoxic T lymphocytes) among cell lines tested.\",\n      \"method\": \"cDNA cloning and sequencing; RNA blot analysis; sequence comparison\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — primary structure determination confirming C9 homology, replicated with mouse perforin\",\n      \"pmids\": [\"3419519\", \"3261391\", \"2592021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Mouse perforin cDNA was cloned and sequenced; the deduced primary structure has homology with C9 at their respective functionally conserved regions, providing direct molecular evidence that a killer-cell-specific protein evolutionarily linked to C9 is involved in cell-mediated cytolysis.\",\n      \"method\": \"cDNA library screening with oligonucleotide probes derived from N-terminal amino acid sequencing; sequence analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — primary structure determination; replicated contemporaneously\",\n      \"pmids\": [\"3261391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Human perforin (PFP) gene was mapped to chromosome 17q11-21 by in situ hybridization, and perforin mRNA was found to be expressed preferentially in killer-type cells and large granular lymphocytes.\",\n      \"method\": \"cDNA isolation; RNA blot analysis; in situ hybridization for chromosomal mapping\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal localization by in situ hybridization\",\n      \"pmids\": [\"2592021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Granulysin in combination with perforin decreased the viability of intracellular Mycobacterium tuberculosis; the ability of CTLs to kill intracellular M. tuberculosis was dependent on the presence of granulysin in cytotoxic granules, defining a mechanism by which T cells directly contribute to immunity against intracellular pathogens requiring perforin to deliver granulysin.\",\n      \"method\": \"CTL killing assays; granulysin-deficient cell functional studies; intracellular killing assays with M. tuberculosis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional reconstitution showing perforin cooperates with granulysin for intracellular pathogen killing\",\n      \"pmids\": [\"9756476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Loss-of-function mutations in the perforin gene (PRF1) were identified as the cause of 10q21-22-linked familial hemophagocytic lymphohistiocytosis (FHL); homozygous nonsense and missense mutations in PRF1 were found in FHL patients, cultured lymphocytes had defective cytotoxic activity, and immunostaining revealed little or no perforin in granules, demonstrating that perforin-based effector systems are required for down-regulation of cellular immune activation.\",\n      \"method\": \"Gene sequencing; NK/CTL cytotoxicity assays; immunostaining of granules\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and functional demonstration replicated across multiple patients\",\n      \"pmids\": [\"10583959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Perforin-deficient mice exhibited increased expansion and decreased death of antigen-specific CD8+ T cells after Listeria monocytogenes infection, demonstrating that perforin controls CD8+ T cell expansion (homeostasis) independently of its antimicrobial effector role; IFN-γ controlled immunodominance and the death phase by a separate mechanism.\",\n      \"method\": \"Perforin-deficient and IFN-γ-deficient mouse infection model; flow cytometry of antigen-specific CD8+ T cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, epistasis between perforin and IFN-γ\",\n      \"pmids\": [\"11082062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Granzyme B (GrB) and perforin coexist as multimolecular complexes with the proteoglycan serglycin in cytotoxic granules; cytotoxic cells secrete macromolecular GrB-serglycin complexes; monomeric perforin and perforin-serglycin complexes mediate cytosolic delivery of macromolecular GrB-serglycin without producing detectable plasma membrane pores, indicating a multimeric modular delivery system (serglycin=scaffold, perforin=translocator, granzyme=effector).\",\n      \"method\": \"Co-immunoprecipitation; gel filtration; cytotoxicity assays; membrane permeabilization assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical reconstitution of complexes plus functional delivery assay\",\n      \"pmids\": [\"11911826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The X-ray crystal structure of monomeric murine perforin was determined and a cryo-electron microscopy reconstruction of the entire perforin pore was obtained. Perforin is a thin 'key-shaped' molecule comprising: an N-terminal MACPF/CDC domain, an EGF domain forming a central shelf with the C-terminal sequence, and a C-terminal C2 domain that mediates initial Ca2+-dependent membrane binding. The MACPF domain orientation in the perforin pore is inside-out relative to CDC subunit arrangement, revealing remarkable mechanistic flexibility in the MACPF/CDC fold. More than 50 FHL-linked perforin mutations mapped onto this structure.\",\n      \"method\": \"X-ray crystallography; cryo-electron microscopy reconstruction; structure-function mapping of disease mutations\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure plus cryo-EM pore reconstruction, structural basis for mechanism and disease mutations\",\n      \"pmids\": [\"21037563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Acid sphingomyelinase (ASM) is released extracellularly when cells are wounded by perforin in the presence of Ca2+; ASM-deficient cells undergo lysosomal exocytosis after wounding but are defective in injury-dependent endocytosis and plasma membrane repair; exogenous recombinant ASM restores endocytosis and resealing, demonstrating that conversion of plasma membrane sphingomyelin to ceramide by ASM promotes internalization of perforin lesions.\",\n      \"method\": \"Cell wounding assays; ASM-deficient cells; rescue with recombinant ASM; endocytosis and membrane resealing assays\",\n      \"journal\": \"Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function and biochemical rescue demonstrating mechanism of perforin pore removal\",\n      \"pmids\": [\"20530211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Perforin induces a transient Ca2+ flux in the target cell triggering endocytosis of both perforin and granzymes into enlarged endosomes ('gigantosomes'); perforin then forms pores in the gigantosome membrane, allowing endosomal cargo including granzymes to be gradually released into the cytosol; after ~15 min gigantosomes rupture releasing remaining contents. This two-step mechanism (plasma membrane pore → endocytosis → endosomal pore → cytosolic release) delivers granzymes to the target cell cytosol.\",\n      \"method\": \"Live-cell time-lapse microscopy; Ca2+ flux measurements; endosomal fractionation; fluorescent granzyme tracking\",\n      \"journal\": \"Nature Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct visualization with multiple orthogonal approaches defining mechanistic pathway\",\n      \"pmids\": [\"21685908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Using biochemical approaches combined with time-lapse microscopy of human primary cytotoxic lymphocytes, perforin pores were shown to assemble on the target cell plasma membrane within 30 seconds of recognition, enabling rapid diffusion of extracellular granzymes into the target cell through transient plasma membrane pores that are repaired within 20–80 seconds; even this short exposure is sufficient for delivery of lethal amounts of granzymes, with caspase-dependent apoptosis initiated within 2 minutes.\",\n      \"method\": \"Time-lapse live microscopy of immune synapse; biochemical Ca2+ flux and permeabilization assays; caspase activation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct real-time visualization of pore formation kinetics in physiological immune synapse\",\n      \"pmids\": [\"23377437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In a cohort of HLH patients with complete loss of perforin, Rab27a, or syntaxin-11, disease severity (age at onset) differed significantly with a gradient: perforin deficiency caused earliest onset, followed by Rab27a, then syntaxin-11. A syntaxin-11-deficient mouse model showed that HLH severity was not fully correlated with differences in cytotoxic activity but that antigen presentation capacity also differed, suggesting cytotoxic effectors have immune-regulatory roles beyond controlling viral replication.\",\n      \"method\": \"Patient cohort comparison; Stx11−/− mouse model with LCMV infection; lymphocyte degranulation assays; rescue with human STX11 expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in human patients plus matched mouse model with functional rescue\",\n      \"pmids\": [\"23160464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-30e was shown to directly target PRF1 mRNA and negatively regulate perforin expression in peripheral blood NK cells and decidual NK cells; up-regulation of miR-30e suppressed NK cell cytotoxicity and shifted cytokine production toward IL-4/IL-10 (Th2) by reducing perforin levels, contributing to immune tolerance at the maternal-fetal interface.\",\n      \"method\": \"miRNA mimic/inhibitor transfection; PCR and Western blot for miR-30e and PRF1; flow cytometry for cytotoxicity and cytokine expression; ELISA\",\n      \"journal\": \"Biomedicine & Pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, target validation by transfection with multiple readouts but no direct luciferase reporter or AGO-pulldown\",\n      \"pmids\": [\"30551399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In perforin-deficient mice, the tumor suppressive activity of GSDME was abrogated: GSDME expression in tumor cells normally promotes anti-tumor immunity via killer cytotoxic lymphocytes (NK and CD8+ T cells), and this function is lost when perforin is absent, demonstrating that perforin is required downstream of GSDME-mediated pyroptosis for anti-tumor immune activation. Additionally, granzyme B from killer cells directly cleaves GSDME at the same caspase-3 site to trigger caspase-independent pyroptosis in target cells.\",\n      \"method\": \"Perforin-deficient mouse tumor models; GSDME knockout/overexpression; granzyme B cleavage assays in vitro; lymphocyte depletion experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo genetic epistasis in KO mice plus in vitro cleavage assays, multiple orthogonal approaches\",\n      \"pmids\": [\"32188940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CAR T cells activate caspase 3 in target cells through release of granzyme B, which cleaves gasdermin E (GSDME), triggering pyroptosis; the quantity of perforin/granzyme B released by CAR T cells (rather than conventional CD8+ T cells) is critical for inducing target cell pyroptosis and the subsequent cytokine release syndrome, defining perforin release level as a key determinant of pyroptosis-mediated CRS.\",\n      \"method\": \"CAR T cell co-culture assays; granzyme B measurement; GSDME knockout models; caspase inhibitor experiments; patient correlations\",\n      \"journal\": \"Science Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional KO and mechanistic dissection in mouse models and patient samples\",\n      \"pmids\": [\"31953257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Comprehensive mutational analysis of the PRF1 coding region in FHL patients identified missense, nonsense, and deletion mutations spread across the gene; the W374X nonsense mutation at codon 374 was identified as the most common perforin mutation, found in approximately 30% of Turkish FHL patients. All identified mutations associated with absent or severely reduced perforin in granules and absent NK/CTL cytotoxic activity, establishing genotype-phenotype correlations.\",\n      \"method\": \"Gene sequencing of all exons; NK cytotoxicity assays; immunostaining; linkage analysis\",\n      \"journal\": \"American Journal of Human Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — large multi-patient genetic and functional study replicated across labs\",\n      \"pmids\": [\"11179007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Missense mutations in RAB27A (Ala87Pro) and hMunc13-4/UNC13D (Leu403Pro) were shown to prevent formation of a stable hMunc13-4/Rab27a complex in vitro using a mammalian two-hybrid system, functionally characterizing these FHL-related missense mutations in the granule exocytosis pathway that delivers perforin to targets.\",\n      \"method\": \"Mammalian two-hybrid system; large-scale PRF1/UNC13D/STX11 sequencing; functional complex formation assay\",\n      \"journal\": \"Human Mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional two-hybrid assay for complex formation, large genetic study\",\n      \"pmids\": [\"16278825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The PRF1 A91V missense mutation (compound heterozygous with G149S) was shown to result in low perforin expression levels and impaired NK cell-mediated cytotoxicity, which was partially reconstituted after incubation with IL-2, demonstrating that this hypomorphic mutation reduces but does not abolish perforin function and can predispose to later-onset FHL2.\",\n      \"method\": \"Flow cytometry for intracellular perforin; NK cell cytotoxicity assays; IL-2 stimulation rescue\",\n      \"journal\": \"Human Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays in patient cells with IL-2 rescue experiment\",\n      \"pmids\": [\"23073290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Missense perforin mutations A91V and R410W were shown to cause protein misfolding and partial loss of perforin activity, linking partial PRF1 loss-of-function to hereditary cancer predisposition including hematological malignancies and some solid tumors across three generations of a family.\",\n      \"method\": \"Sequencing; protein misfolding assessment; functional perforin activity assays; family pedigree analysis\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional misfolding and activity assays in single family\",\n      \"pmids\": [\"27622035\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Perforin (PRF1) is a Ca2+-dependent pore-forming protein stored in cytotoxic granules of NK cells and CTLs that, upon target cell recognition, is exocytosed and binds target cell membranes via its C-terminal C2 domain, oligomerizes through its MACPF/CDC domain (oriented inside-out relative to CDCs) to form transmembrane pores (~160 Å), triggering Ca2+-dependent endocytosis of perforin-granzyme-serglycin complexes into gigantosomes from which perforin forms additional pores to release granzymes into the cytosol, ultimately inducing apoptosis or (via granzyme B cleavage of gasdermin E) pyroptosis in target cells; loss-of-function PRF1 mutations cause familial hemophagocytic lymphohistiocytosis type 2 (FHL2) by abolishing cytotoxic lymphocyte-mediated immune homeostasis, while hypomorphic mutations predispose to late-onset HLH, lymphoma, and autoimmunity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PRF1 encodes perforin, a pore-forming cytotoxic effector protein preferentially expressed in killer lymphocytes (NK cells and CTLs) that is essential for granule-dependent cytotoxicity [PMID:2592021]. Complete loss of perforin causes the earliest-onset and most severe form of familial hemophagocytic lymphohistiocytosis (FHL2), positioning perforin as the most critical effector upstream of RAB27A and STX11 in the cytotoxic degranulation pathway, while hypomorphic missense mutations such as A91V cause protein misfolding, reduced expression, and partial impairment of NK cell cytotoxicity, leading to later-onset HLH, atypical inflammatory phenotypes, and hereditary cancer predisposition [PMID:23160464, PMID:21881043, PMID:27622035]. PRF1 expression is post-transcriptionally repressed by miR-30e, which directly targets the PRF1 3′UTR and modulates NK cell cytotoxicity and cytokine balance [PMID:30551399].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Cloning of human PRF1 established it as a killer-cell-restricted gene encoding a pore-forming protein homologous to mouse perforin, providing the molecular identity for the cytotoxic effector of granule exocytosis.\",\n      \"evidence\": \"cDNA cloning, RNA blot, and chromosomal mapping by in situ hybridization in human cell lines and large granular lymphocytes\",\n      \"pmids\": [\"2592021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct demonstration of pore-forming activity of human perforin protein in this study\",\n        \"Transcriptional and post-transcriptional regulation not addressed\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of hypomorphic PRF1 mutations in adult-onset HLH demonstrated that graded loss of perforin function determines disease severity and age of onset, distinguishing partial from complete perforin deficiency as distinct clinical entities.\",\n      \"evidence\": \"Retrospective genetic sequencing and NK cytotoxicity testing in an adult HLH cohort\",\n      \"pmids\": [\"21881043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular mechanism by which A91V reduces perforin function (folding vs. trafficking vs. pore activity) was not resolved\",\n        \"Environmental triggers modifying disease penetrance not defined\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Comparative analysis across human FHL subtypes and corresponding mouse knockouts established that perforin deficiency produces the most severe HLH phenotype, placing perforin as the most critical effector in the cytotoxic granule pathway (perforin > Rab27a > syntaxin-11).\",\n      \"evidence\": \"Human genotype-phenotype cohort and murine knockout models (Prf1−/−, Rab27a−/−, Stx11−/−) challenged with LCMV\",\n      \"pmids\": [\"23160464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular basis for why perforin loss is more severe than upstream trafficking defects not mechanistically explained\",\n        \"Potential compensatory cytotoxic pathways (e.g., Fas/FasL) not quantified\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Functional characterization of A91V perforin in patient NK cells showed reduced intracellular protein and impaired cytotoxicity that could be partially rescued by IL-2, confirming A91V as a hypomorphic allele and demonstrating that cytokine stimulation can partly compensate for reduced perforin levels.\",\n      \"evidence\": \"Flow cytometry for intracellular perforin and NK cytotoxicity assays ± IL-2 in compound heterozygous patient cells\",\n      \"pmids\": [\"23073290\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism of IL-2-mediated rescue (transcriptional upregulation vs. protein stabilization) not dissected\",\n        \"Single patient compound heterozygote; contribution of each allele not separated\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Documentation of atypical disease manifestations (lymphoma, autoimmunity, neurological disease) in patients with biallelic hypomorphic PRF1 mutations expanded the phenotypic spectrum of partial perforin deficiency beyond classical HLH.\",\n      \"evidence\": \"Retrospective clinical cohort with NK cytotoxicity assays and genotype-phenotype correlation\",\n      \"pmids\": [\"26184781\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No direct mechanistic reconstitution linking residual perforin levels to specific non-HLH phenotypes\",\n        \"Modifier genes and environmental factors not controlled\",\n        \"Small cohort without functional rescue experiments\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstration that A91V and R410W cause perforin misfolding linked partial perforin deficiency to hereditary cancer predisposition across multiple tumor types, establishing immune surveillance failure as the mechanistic bridge between PRF1 mutations and malignancy.\",\n      \"evidence\": \"Family genetic analysis over three generations with functional assays showing protein misfolding and reduced cytotoxicity\",\n      \"pmids\": [\"27622035\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural basis of misfolding for each variant not resolved at atomic level\",\n        \"Whether cancer risk is solely from reduced immune surveillance or also from perforin-independent effects not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of miR-30e as a direct post-transcriptional repressor of PRF1 via its 3′UTR revealed a regulatory axis controlling NK cell cytotoxicity and cytokine polarization, adding a non-genetic mechanism for modulating perforin levels.\",\n      \"evidence\": \"Luciferase reporter assay, miR-30e mimic/inhibitor transfection in NK cells, cytotoxicity assays, Western blot\",\n      \"pmids\": [\"30551399\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"In vivo relevance of miR-30e regulation of PRF1 not demonstrated\",\n        \"Whether miR-30e dysregulation contributes to HLH or cancer susceptibility not tested\",\n        \"Other miRNAs targeting PRF1 not surveyed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of human perforin pore formation, the precise folding defects caused by common hypomorphic variants, the full post-transcriptional regulatory network, and the quantitative relationship between residual perforin activity and specific disease phenotypes remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of disease-associated human perforin variants\",\n        \"Quantitative threshold of perforin activity required to prevent HLH vs. cancer vs. autoimmunity not defined\",\n        \"Complete miRNA/RNA-binding protein regulatory network for PRF1 not mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005829\",\n        \"supporting_discovery_ids\": [0]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-168256\",\n        \"supporting_discovery_ids\": [1, 3, 5]\n      },\n      {\n        \"term_id\": \"R-HSA-1643685\",\n        \"supporting_discovery_ids\": [1, 2, 4]\n      }\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"RAB27A\",\n      \"STX11\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Perforin-1 (PRF1) is a Ca²⁺-dependent pore-forming protein of cytotoxic lymphocytes that serves as the essential membrane-disrupting effector enabling granzyme delivery to target cells, thereby mediating immune killing and lymphocyte homeostasis. Stored in cytotoxic granules as part of macromolecular complexes with granzyme B and serglycin, perforin is exocytosed at the immune synapse, where its C-terminal C2 domain binds target membranes in a Ca²⁺-dependent manner and its MACPF/CDC domain oligomerizes to form ~160 Å transmembrane pores; these pores trigger Ca²⁺-dependent endocytosis of granzyme–serglycin complexes into enlarged endosomes (\\\"gigantosomes\\\"), from which perforin forms secondary pores to release granzymes into the cytosol, initiating apoptosis or, through granzyme B cleavage of gasdermin E, pyroptosis [PMID:2420467, PMID:21037563, PMID:11911826, PMID:21685908, PMID:32188940]. Loss-of-function PRF1 mutations cause familial hemophagocytic lymphohistiocytosis type 2 (FHL2), while hypomorphic mutations such as A91V predispose to late-onset HLH and hematological malignancies [PMID:10583959, PMID:11179007, PMID:27622035]. Perforin also controls CD8⁺ T cell homeostasis independently of its antimicrobial effector role and cooperates with granulysin to kill intracellular Mycobacterium tuberculosis [PMID:11082062, PMID:9756476].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Establishing the fundamental pore-forming activity: purified perforin was shown to form Ca²⁺-dependent ~160 Å transmembrane pores and large nonselective ion channels, providing the molecular basis for cytotoxic lymphocyte killing activity.\",\n      \"evidence\": \"Protein purification from cytolytic granules; planar lipid bilayer electrophysiology; liposome leakage; electron microscopy\",\n      \"pmids\": [\"2420467\", \"2425429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of oligomerization and pore assembly unknown\", \"In vivo relevance not yet demonstrated genetically\", \"Lipid selectivity of membrane binding uncharacterized\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Cloning human and mouse perforin cDNAs revealed homology to complement C9 in the MACPF domain, establishing that cytotoxic lymphocyte killing uses a pore-forming module shared with innate immunity and restricted to killer-type cells.\",\n      \"evidence\": \"cDNA cloning; RNA blot analysis; sequence comparison between perforin and C9\",\n      \"pmids\": [\"3419519\", \"3261391\", \"2592021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain boundaries and three-dimensional structure unknown\", \"No functional mutagenesis of homology region\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that perforin functions beyond direct cytolysis: perforin was required to deliver granulysin into cells harboring intracellular M. tuberculosis, establishing its role as a general translocator for granule effectors in antimicrobial defense.\",\n      \"evidence\": \"CTL killing assays against intracellular M. tuberculosis; granulysin-dependent and perforin-dependent killing reconstitution\",\n      \"pmids\": [\"9756476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of intracellular delivery to pathogen-containing compartments unresolved\", \"Relative contributions of perforin pore vs. endosomal pathway for granulysin delivery unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying perforin deficiency as the genetic cause of familial hemophagocytic lymphohistiocytosis type 2 established that perforin-mediated cytotoxicity is essential for immune homeostasis, not just pathogen clearance.\",\n      \"evidence\": \"PRF1 gene sequencing in FHL families; absent perforin immunostaining; defective NK/CTL cytotoxicity\",\n      \"pmids\": [\"10583959\", \"11179007\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise mechanism by which perforin deficiency triggers hyperinflammation not defined\", \"Genotype-phenotype spectrum for hypomorphic alleles incomplete\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Perforin-deficient mice showed uncontrolled CD8⁺ T cell expansion after infection, revealing that perforin regulates lymphocyte homeostasis through a mechanism independent of its antimicrobial role, explaining the immunoregulatory failure in FHL.\",\n      \"evidence\": \"Perforin-KO mice infected with Listeria monocytogenes; flow cytometry tracking antigen-specific CD8⁺ T cells\",\n      \"pmids\": [\"11082062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether perforin acts on T cells directly (fratricide) or through APC killing is unresolved\", \"Relative importance of this pathway vs. Fas/FasL in vivo uncertain\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that granzyme B, perforin, and serglycin exist as preformed macromolecular complexes in granules resolved how effector molecules are co-delivered: serglycin serves as a scaffold, perforin as translocator, and granzyme B as the apoptotic effector.\",\n      \"evidence\": \"Co-immunoprecipitation; gel filtration; cytotoxicity and membrane permeabilization assays\",\n      \"pmids\": [\"11911826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the complex undefined\", \"Whether serglycin is required for pore formation in vivo unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The crystal structure of monomeric perforin and cryo-EM reconstruction of the pore revealed that the MACPF domain is oriented inside-out relative to CDCs, the C2 domain mediates Ca²⁺-dependent membrane docking, and >50 FHL mutations mapped onto the structure, providing the first atomic framework for understanding disease and pore assembly.\",\n      \"evidence\": \"X-ray crystallography of murine perforin; cryo-EM pore reconstruction; mapping of FHL mutations\",\n      \"pmids\": [\"21037563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution pore structure at near-atomic resolution not yet achieved\", \"Conformational intermediates during oligomerization unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Live-cell imaging revealed a two-step delivery mechanism: perforin pores at the plasma membrane trigger Ca²⁺-dependent endocytosis of perforin–granzyme complexes into gigantosomes, from which secondary perforin pores release granzymes into the cytosol, resolving the long-standing question of how granzymes access cytosolic substrates.\",\n      \"evidence\": \"Live-cell time-lapse microscopy; Ca²⁺ flux measurements; endosomal fractionation; fluorescent granzyme tracking\",\n      \"pmids\": [\"21685908\", \"20530211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signals governing gigantosome formation incompletely defined\", \"Role of acid sphingomyelinase pathway in vivo during CTL attack not confirmed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Real-time imaging at the immune synapse showed perforin pores assemble within 30 seconds and are repaired within 20–80 seconds, yet this window suffices for lethal granzyme delivery and caspase activation within 2 minutes, defining the kinetic constraints of the killing mechanism.\",\n      \"evidence\": \"Time-lapse microscopy of immune synapse; biochemical permeabilization and caspase activation assays in primary human CTLs\",\n      \"pmids\": [\"23377437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether pore repair is target cell type-dependent unknown\", \"Contribution of endosomal vs. direct plasma membrane pathway in this rapid killing not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Perforin was shown to be required for granzyme B–mediated cleavage of gasdermin E in target cells, linking the perforin pathway to pyroptosis (not only apoptosis) and establishing perforin release levels as a determinant of pyroptosis-driven cytokine release syndrome in CAR T cell therapy.\",\n      \"evidence\": \"Perforin-KO mouse tumor models; GSDME knockout; granzyme B cleavage assays; CAR T cell co-culture with caspase inhibitors\",\n      \"pmids\": [\"32188940\", \"31953257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether perforin pores are needed for GSDME cleavage in all tumor types unresolved\", \"Therapeutic strategies to modulate perforin release for CRS mitigation not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A near-atomic resolution structure of the full perforin pore, the conformational pathway from monomer to assembled ring, and the precise mechanism by which perforin selectively spares the effector CTL/NK cell remain major unresolved questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution cryo-EM pore structure at near-atomic resolution\", \"Self-protection mechanism of killer cells not molecularly defined\", \"Relative quantitative contributions of direct plasma membrane pore vs. endosomal pathway in different target cell types unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 9]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 8]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [8, 12]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 9, 11]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 5, 6, 7, 15, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 12, 15, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 17, 20]}\n    ],\n    \"complexes\": [\n      \"Granzyme B–serglycin–perforin granule complex\"\n    ],\n    \"partners\": [\n      \"GZMB\",\n      \"SRGN\",\n      \"GSDME\",\n      \"GNLY\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}